Droperidol (Hospira, Inc.)
Welcome to the PulseAid listing for the Droperidol drug offered from Hospira, Inc.. This Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hospira, Inc. |
NON-PROPRIETARY NAME: | DROPERIDOL |
SUBSTANCE NAME: | DROPERIDOL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC] |
ROUTE: | INTRAMUSCULAR; INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 1988-02-29 |
END MARKETING DATE: | 0000-00-00 |
Droperidol HUMAN PRESCRIPTION DRUG Details:
Item Description | Droperidol from Hospira, Inc. |
LABELER NAME: | Hospira, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2.5(mg/mL) |
START MARKETING DATE: | 1988-02-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0409-1187_dbe5ebe3-9ef5-4cf7-b00d-c178c9a518e2 |
PRODUCT NDC: | 0409-1187 |
APPLICATION NUMBER: | ANDA071981 |
Other DROPERIDOL Pharmaceutical Manufacturers / Labelers: